Actavis Luxembourg
Aktuelles Alle(s) Internal Produkt Commitment Anderes Year Alle(s) 2012 2011 2010 2009
Global managed-care offering to help bring down treatment costs for 366 million diabetics Actavis and Bioton (WSE:BIO) announced today that they have formed a joint venture company for the
Actavis Group, the international generic pharmaceuticals company, has acquired 100% of the shares in PharmaPack International B.V. for an undisclosed amount. PharmaPack is based in Zoetermeer,
Company to address future challenges with new ‘think smart medicine’ approach Zug, Switzerland, 3 November 2011 ― At a press meeting to explain the new strategy of Actavis, CEO Claudio Albrecht